EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.24.43 | Dimethylcasein + H2O |
- |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Fibrin + H2O |
both alpha and beta chains hydrolyzed, but the gamma-gamma chain not affected |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Fibrinogen + H2O |
Aalpha and Bbeta chains readily hydrolyzed, but gamma chain resistant to hydrolysis |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Human fibrinogen + H2O |
gamma chain is not hydrolyzed |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Human fibrinogen + H2O |
hydrolysis of Aalpha and Bbeta chain, cleavage pattern different from thrombin cleavage pattern |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | more |
no hemorrhagic activity, no substrates are thrombin, synthetic substrate for thrombin S-2238 |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | more |
nontoxic venom component, nonhemorrhagic endopeptidase |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | more |
no hydrolysis of the synthetic substrate S-2238 for thrombin |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Oxidized insulin B-chain |
cleavage of His5-Leu6, Ser9-His10, His10-Leu11, Ala14-Leu15, Tyr16-Leu17 |
Crotalus atrox |
? |
- |
? |
3.4.24.43 | Oxidized insulin B-chain + H2O |
- |
Crotalus atrox |
? |
- |
? |